-
CLINICAL OUTCOMES AND COST-EFFECTIVENESS OF PEMBROLIZUMAB IN GREECE: AN MODELING ANALYSIS BASED ON 22 INDICATIONS
Aug 11, 2026, 17:15 PM -
DEVELOPING A REPRODUCIBLE TRANSPORTABILITY FRAMEWORK FOR REAL-WORLD EXTERNAL CONTROL ARMS: AN ADULT SEPSIS EXAMPLE USING MIMIC IV
Aug 11, 2026, 17:15 PM -
NAVIGATING THE PAIC MAZE, REVISITED: METHODOLOGICAL UPDATES AND REGULATORY REALITIES IN NICE SUBMISSIONS
Aug 11, 2026, 17:15 PM -
NO COUNTRY FOR OLD MEN: AGE-GEOGRAPHIC CONVERGENCE OF UNMET NEED IN ANTI-VEGF THERAPY FOR NEOVASCULAR AMD IN CZECHIA ACCORDING TO A NATIONAL EPIDEMIOLOGICAL-ACCESSIBILITY ANALYSIS
Aug 11, 2026, 17:15 PM -
PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF INCREASING LAIV UPTAKE IN ESTONIAN CHILDREN
Aug 11, 2026, 17:15 PM -
DOES A SLEEP BOLT-ON IMPROVE THE MEASUREMENT OF HEALTH-RELATED QUALITY OF LIFE AMONG COMMUNITY MENTAL HEALTH SERVICE USERS? EVIDENCE FROM HONG KONG
Aug 11, 2026, 17:15 PM -
HEALTHCARE RESOURCE UTILISATION AND COSTS ASSOCIATED WITH BULLOUS PEMPHIGOID IN ENGLAND: A RETROSPECTIVE MATCHED COHORT STUDY
Aug 11, 2026, 17:15 PM -
ADHERENCE TO DATA COLLECTION IN REAL-WORLD STUDIES: THE IMPACT OF COMPENSATION AND ENGAGEMENT STRATEGIES
Aug 11, 2026, 17:15 PM -
WHAT THE TEMPLATE DOESN'T SAY: STRATEGIC FLEXIBILITY IN THE JCA DOSSIER
Aug 11, 2026, 17:15 PM -
LEVEL OF ICER OF HEALTH ECONOMIC ASSESSMENTS IN FRANCE IN 2025
Aug 11, 2026, 17:15 PM -
TERRITORIAL DETERMINANTS OF HEALTHCARE EXPENDITURES IN FRENCH DEPARTMENTS: AN EXPOSOME-BASED MULTIPLE LINEAR REGRESSION ANALYSIS
Aug 11, 2026, 17:15 PM -
GLOBAL ECONOMIC BURDEN AND QUALITY OF LIFE IMPLICATIONS OF MULTIPLE SCLEROSIS IN ALGERIA: A SOCIETAL PERSPECTIVE AND MULTIVARIATE ANALYSIS
Aug 11, 2026, 17:15 PM -
BUDGET IMPACT ANALYSIS OF THE REVISED BREAST CANCER SCREENING PROGRAM IN HUNGARY
Aug 11, 2026, 17:15 PM -
REAL-WORLD HEALTHCARE RESOURCE USE AND ASSOCIATED COSTS OF EVERY-2-MONTHS LONG-ACTING CABOTEGRAVIR + RILPIVIRINE IN SPAIN: A POST-LAUNCH COMPARISON WITH DAILY ORAL HIV TREATMENTS
Aug 11, 2026, 17:15 PM -
DRIVERS OF DECISIONS FOR FIRST-LINE (1L) TREATMENT IN METASTATIC UROTHELIAL CANCER (MUC): RESULTS FROM A REAL-WORLD SURVEY OF PHYSICIANS IN 5 EUROPEAN COUNTRIES
Aug 11, 2026, 17:15 PM -
THE WAKING BURDEN OF NIGHT-TIME SEIZURES: A SYSTEMATIC REVIEW OF QUALITY OF LIFE IN NOCTURNAL EPILEPSY
Aug 11, 2026, 17:15 PM -
DIGITAL TRANSFORMATION IN OBESITY CARE: EVALUATING THE IMPACT OF A HYBRID DIGITAL CARE PATHWAY ON NHS CAPACITY IN SOUTH EAST LONDON?
Aug 11, 2026, 17:15 PM -
ESTIMATING THE VALUE-BASED PRICE OF EPCORITAMAB VERSUS POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN EGYPT: A COST-UTILITY MODEL
Aug 11, 2026, 17:15 PM -
IMPACT OF TIME-TO-EVENT EXTRAPOLATION ON 36-MONTH TARGET LESION REVASCULARISATION ESTIMATES FOR COVERED BALLOON-EXPANDABLE STENTS IN AORTOILIAC OCCLUSIVE DISEASE
Aug 11, 2026, 17:15 PM -
WHICH ARTICLES STILL NEED HUMAN EYES? A VALIDATED, SCORE-TIERED FRAMEWORK FOR AI-ASSISTED LITERATURE SCREENING
Aug 11, 2026, 17:15 PM
